MDIC is working with various stakeholders including FDA, industry, academia international non-profit organizations like Avicenna Alliance to transform computational modeling and simulation (CM&S) from ‘a valuable scientific tool’ to a ‘valuable regulatory tool’ as well as to develop mechanisms to rely more on digital evidence. To achieve this objective, the community need frameworks and good simulation practices to support the evaluation and utility of CM&S in health technologies. In this APF session, specifically focused on CM&S, attendees will learn about the recent global developments in this front. The session also will overview the learnings from MDIC CM&S landscape survey conducted in summer 2020.
Speakers:
Tina Morrison, PhD | FDA
Randy Shiestl, PMP | Boston Scientific
Steven Levine, PhD | Dassault Systèmes
Markus Reiterer, PhD | Medtronic
Pras Pathmanathan, PhD | FDA
